Microglial dynamics and role in the healthy and diseased brain: A paradigm of functional plasticity

Neuroscientist

Volumn 21, Issue 2, 2015, Pages 169-184

  Gomez Nicola, Diego ^a   Perry, V Hugh ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

microglia; neuroinflammation; neuromodulation; phagocytosis; proliferation; surveillance; synaptic pruning

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; GLYCOPROTEIN P 15095; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN; BRAIN DISEASE; CELL MIGRATION; CELL PROLIFERATION; CYTOARCHITECTURE; HUMAN; HUNTINGTON CHOREA; INFLAMMATION; MACROPHAGE; MICROGLIA; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PRION DISEASE; PRIORITY JOURNAL; REVIEW; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; BRAIN DISEASES; CELL PROLIFERATION; HUMANS; MICROGLIA; NEURONAL PLASTICITY;

EID: 84924976223     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858414530512     Document Type: Review

References (152)

1. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci. 2011 ; 14 (9). 1142-9
2. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci. 2007 ; 10 (12). 1538-43
3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000 ; 21 (3). 383-421
4. Akiyama H, Nishimura T, Kondo H, Ikeda K, Hayashi Y, McGeer PL. Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis. Brain Res. 1994 ; 639 (1). 171-4
5. Alliot F, Godin I, Pessac B.. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res. 1999 ; 117 (2). 145-52
6. Audet JN, Gowing G, Paradis R, Soucy G, Julien JP. Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase. PLoS One. 2012 ; 7 (4). e34932
7. Bechade C, Cantaut-Belarif Y, Bessis A.. Microglial control of neuronal activity. Front Cell Neurosci. 2013 ; 7: 32
8. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2006 ; 103 (43). 16021-6
9. Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010 ; 68 (1). 19-31
10. Billadeau DD, Leibson PJ. ITAMs versus ITIMs: striking a balance during cell regulation. J Clin Invest. 2002 ; 109 (2). 161-8
11. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A. 2004 ; 101 (7). 2173-8
12. Blinzinger K, Kreutzberg G.. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat. 1968 ; 85 (2). 145-57
13. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013 ; 39 (1). 3-18
14. Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci. 2008 ; 28 (16). 4283-92
15. Brown GC, Neher JJ. Eaten alive! Cell death by primary phagocytosis: "phagoptosis.". Trends Biochem Sci. 2012 ; 37 (8). 325-32
16. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci. 2014 ; 17 (1). 131-43
17. Chan A, Hummel V, Weilbach FX, Kieseier BC, Gold R.. Phagocytosis of apoptotic inflammatory cells downregulates microglial chemoattractive function and migration of encephalitogenic T cells. J Neurosci Res. 2006 ; 84 (6). 1217-24
18. Chan WY, Kohsaka S, Rezaie P.. The origin and cell lineage of microglia: new concepts. Brain Res Rev. 2007 ; 53 (2). 344-54
19. Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013 ; 504 (7480). 394-400
20. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation. 2006 ; 3: 27
21. Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation.. 2012 ; 9: 179
22. Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014 ;:
23. Crutcher KA, Gendelman HE, Kipnis J, Perez-Polo JR, Perry VH, Popovich PG. Debate: "Is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol. 2006 ; 1 (3). 195-211
24. Dalmau I, Finsen B, Zimmer J, Gonzalez B, Castellano B.. Development of microglia in the postnatal rat hippocampus. Hippocampus. 1998 ; 8 (5). 458-74
25. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010 ; 468 (7323). 562-6
26. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005 ; 8 (6). 752-8
27. Dawson TM, Ko HS, Dawson VL. Genetic animal models of Parkinson's disease. Neuron. 2010 ; 66 (5). 646-61
28. del Rio Hortega P Penfield W, ed. New York, NY: Hoeber ; 1932: 481-534.
29. del Rio Hortega P, Penfield W. Cerebral cicatrix. The reaction of neuroglia and microglia to brain wounds. Bull Johns Hopkins Hosp. 1927 ; 41: 278-82
30. Del Rio-Hortega P. La microglia y su transformacion en células en bastoncito y cuerpos granulo-adiposos. Trabajos del laboratorio de investigaciones biologicas. 1920 ; 18 ( 37 ):
31. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C.. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 1993 ; 7 (1). 75-83
32. Ding Z, Mathur V, Ho PP, James ML, Lucin KM, Hoehne A. Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation. J Exp Med. 2014 ; 211 (2). 189-98
33. Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE. Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis. 2008 ; 32 (3). 412-9
34. Esiri MM, al Izzi MS, Reading MC. Macrophages, microglial cells, and HLA-DR antigens in fetal and infant brain. J Clin Pathol. 1991 ; 44 (2). 102-6
35. Fernandez-Botran R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson DW. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord. 2011 ; 17: 683-8
36. Fiske BK, Brunjes PC. Microglial activation in the developing rat olfactory bulb. Neuroscience. 2000 ; 96 (4). 807-15
37. Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011 ; 124 (Pt 3). 447-58
38. Fontainhas AM, Wang M, Liang KJ, Chen S, Mettu P, Damani M. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PLoS One. 2011 ; 6 (1). e15973
39. Franciosi S, Ryu JK, Shim Y, Hill A, Connolly C, Hayden MR. Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease. Neurobiol Dis. 2012 ; 45 (1). 438-49
40. Frank S, Burbach GJ, Bonin M, Walter M, Streit W, Bechmann I. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia. 2008 ; 56 (13). 1438-47
41. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol. 1998 ; 152 (1). 307-17
42. Fricker M, Neher JJ, Zhao JW, Thery C, Tolkovsky AM, Brown GC. MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation. J Neurosci. 2012 ; 32 (8). 2657-66
43. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis. 2006 ; 21 (2). 404-12
44. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010 ; 330 (6005). 841-5
45. Ginhoux F, Lim S, Hoeffel G, Low D, Huber T.. Origin and differentiation of microglia. Front Cell Neurosci. 2013 ; 7: 45
46. Gomez-Nicola D, Fransen NL, Suzzi S, Perry VH. Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci. 2013 ; 33 (6). 2481-93
47. Gomez-Nicola D, Schetters STT, Perry VH. Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease. Glia. 2014 ;:
48. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003 ; 3 (1). 23-35
49. Gowing G, Lalancette-Hebert M, Audet JN, Dequen F, Julien JP. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase. Exp Neurol. 2009 ; 220 (2). 267-75
50. Gowing G, Philips T, Van Wijmeersch B, Audet JN, Dewil M, Van Den Bosch L. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci. 2008 ; 28 (41). 10234-44
51. Grathwohl SA, Kalin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci. 2009 ; 12 (11). 1361-3
52. Griffin WS, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol. 1995 ; 54 (2). 276-81
53. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989 ; 86 (19). 7611-5
54. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013 ; 368 (2). 117-27
55. Hanisch UK, Kettenmann H.. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007 ; 10 (11). 1387-94
56. Hefendehl JK, Neher JJ, Suhs RB, Kohsaka S, Skodras A, Jucker M.. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell. 2014 ; 13 (1). 60-9
57. Heneka MT, O'Banion MK. Inflammatory processes in Alzheimer's disease. J Neuroimmunol. 2007 ; 184 (1-2). 69-91
58. Herber DL, Roth LM, Wilson D, Wilson N, Mason JE, Morgan D. Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Exp Neurol. 2004 ; 190 (1). 245-53
59. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013 ; 16 (12). 1896-905
60. Hines DJ, Hines RM, Mulligan SJ, Macvicar BA. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia. 2009 ; 57 (15). 1610-8
61. Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH. Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology. 2011 ; 77 (3). 212-8
62. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009 ; 73 (10). 768-74
63. Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology. CNS Neurol Disord Drug Targets.. 2011 ; 10 (1). 57-67
64. Hosmane S, Tegenge MA, Rajbhandari L, Uapinyoying P, Kumar NG, Thakor N. Toll/interleukin-1 receptor domain-containing adapter inducing interferon-beta mediates microglial phagocytosis of degenerating axons. J Neurosci. 2012 ; 32 (22). 7745-57
65. Hua JY, Smith SJ. Neural activity and the dynamics of central nervous system development. Nat Neurosci. 2004 ; 7 (4). 327-32
66. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C.. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia. 2010 ; 58 (16). 2017-30
67. Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience. 1996 ; 72 (2). 355-63
68. Hutchins KD, Dickson DW, Rashbaum WK, Lyman WD. Localization of morphologically distinct microglial populations in the developing human fetal brain: implications for ontogeny. Brain Res Dev Brain Res. 1990 ; 55 (1). 95-102
69. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2013 ; 368 (2). 107-16
70. Jucker M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med. 2010 ; 16 (11). 1210-4
71. Kamphuis W, Orre M, Kooijman L, Dahmen M, Hol EM. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia. 2012 ; 60 (4). 615-29
72. Katz LC, Shatz CJ. Synaptic activity and the construction of cortical circuits. Science. 1996 ; 274 (5290). 1133-8
73. Kempermann G, Jessberger S, Steiner B, Kronenberg G.. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004 ; 27 (8). 447-52
74. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A.. Physiology of microglia. Physiol Rev. 2011 ; 91 (2). 461-553
75. Kettenmann H, Kirchhoff F, Verkhratsky A.. Microglia: new roles for the synaptic stripper. Neuron. 2013 ; 77 (1). 10-8
76. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci. 2013 ; 16 (3). 273-80
77. Kraft AD, Kaltenbach LS, Lo DC, Harry GJ. Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons. Neurobiol Aging. 2012 ; 33 621 (3). e17 - e33
78. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996 ; 19 (8). 312-8
79. LaFerla FM, Oddo S.. Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol Med. 2005 ; 11 (4). 170-6
80. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009 ; 41 (10). 1094-9
81. Lawson LJ, Perry VH, Dri P, Gordon S.. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990 ; 39 (1). 151-70
82. Lawson LJ, Perry VH, Gordon S.. Turnover of resident microglia in the normal adult mouse brain. Neuroscience. 1992 ; 48 (2). 405-15
83. Li T, Pang S, Yu Y, Wu X, Guo J, Zhang S.. Proliferation of parenchymal microglia is the main source of microgliosis after ischaemic stroke. Brain. 2013 ; 136 (Pt 12). 3578-88
84. Liang KJ, Lee JE, Wang YD, Ma W, Fontainhas AM, Fariss RN. Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling. Invest Ophthalmol Vis Sci. 2009 ; 50 (9). 4444-51
85. Ling EA, Penney D, Leblond CP. Use of carbon labeling to demonstrate the role of blood monocytes as precursors of the "ameboid cells" present in the corpus callosum of postnatal rats. J Comp Neurol. 1980 ; 193 (3). 631-57
86. Maezawa I, Jin LW. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci. 2010 ; 30 (15). 5346-56
87. Magnus T, Chan A, Grauer O, Toyka KV, Gold R.. Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol. 2001 ; 167 (9). 5004-10
88. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett. 1989 ; 107 (1-3). 341-6
89. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988 ; 38 (8). 1285-91
90. McGeer PL, McGeer EG. The possible role of complement activation in Alzheimer disease. Trends Mol Med. 2002 ; 8 (11). 519-23
91. McGeer PL, Schwab C, Parent A, Doudet D.. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol. 2003 ; 54 (5). 599-604
92. Mildner A, Schlevogt B, Kierdorf K, Bottcher C, Erny D, Kummer MP. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci. 2011 ; 31 (31). 11159-71
93. Ming GL, Song H.. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron.. 2011 ; 70 (4). 687-702
94. Mittelbronn M, Dietz K, Schluesener HJ, Meyermann R.. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. 2001 ; 101 (3). 249-55
95. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol. 2012 ; 188 (1). 29-36
96. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994 ; 180 (2). 147-50
97. Moller T. Neuroinflammation in Huntington's disease. J Neural Transm. 2010 ; 117 (8). 1001-8
98. Morris L, Graham CF, Gordon S.. Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80. Development. 1991 ; 112 (2). 517-6
99. Neher JJ, Emmrich JV, Fricker M, Mander PK, Thery C, Brown GC. Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc Natl Acad Sci U S A. 2013 ; 110 (43). E4098-107
100. Neher JJ, Neniskyte U, Zhao JW, Bal-Price A, Tolkovsky AM, Brown GC. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol. 2011 ; 186 (8). 4973-83
101. Neumann H, Misgeld T, Matsumuro K, Wekerle H.. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci U S A.. 1998 ; 95 (10). 5779-84
102. Nielsen HH, Ladeby R, Fenger C, Toft-Hansen H, Babcock AA, Owens T. Enhanced microglial clearance of myelin debris in T cell-infiltrated central nervous system. J Neuropathol Exp Neurol. 2009 ; 68 (8). 845-56
103. Nimmerjahn A, Kirchhoff F, Helmchen F.. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005 ; 308 (5726). 1314-8
104. Nissl F. Ueber einige Beziehungen zwishcen Nerven zellerkrankungen und gliosen Erscheinnungen bei verschiedenen Psychosen. Arch Psychiat. 1899 ; 32: 1-21
105. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011 ; 333 (6048). 1456-8
106. Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A.. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci U S A. 2012 ; 109 (4). E197 - E205
107. Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology.. 2006 ; 66 (11). 1638-43
108. Perry VH. Innate inflammation in Parkinson's disease. Cold Spring Harb Perspect Med. 2012 ; 2 (9). a009373
109. Perry VH, Cunningham C, Holmes C.. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007 ; 7 (2). 161-7
110. Perry VH, Holmes C.. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014 2014 ;:
111. Perry VH, Hume DA, Gordon S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience. 1985 ; 15 (2). 313-26
112. Perry VH, O'Connor V.. The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective. ASN Neuro. 2010 ; 2 (5). e00047
113. Perry VH, Teeling J.. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol. 2013 ; 35 (5). 601-12
114. Pocock JM, Kettenmann H.. Neurotransmitter receptors on microglia. Trends Neurosci. 2007 ; 30 (10). 527-35
115. Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp. 2011 ; 32 (2). 258-70
116. Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS?. Nat Rev Neurosci. 2008 ; 9 (6). 481-93
117. Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain. 2008 ; 131 (Pt 7). 1880-94
118. Prinz M, Mildner A.. Microglia in the CNS: immigrants from another world. Glia. 2011 ; 59 (2). 177-87
119. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009 ; 27: 119-45
120. Rezaie P, Male D.. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech. 1999 ; 45 (6). 359-82
121. Robertson W. A microscopic demonstration of the normal and pathological histology of mesoglia cells. J Ment Sci. 1900 ; 46: 733-52
122. Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol. 2001 ; 60 (2). 161-72
123. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012 ; 74 (4). 691-705
124. Schafer DP, Lehrman EK, Stevens B.. The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS. Glia. 2013 ; 61 (1). 24-36
125. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012 ; 336 (6077). 86-90
126. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE, O'Banion MK. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest. 2007 ; 117 (6). 1595-604
127. Sierra A, Abiega O, Shahraz A, Neumann H.. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci. 2013 ; 7: 6
128. Sierra A, Encinas JM, Deudero JJ, Chancey JH, Enikolopov G, Overstreet-Wadiche LS. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell. 2010 ; 7 (4). 483-95
129. Simard AR, Rivest S.. Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol Psychiatry. 2006 ; 11 (4). 327-35
130. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S.. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron. 2006 ; 49 (4). 489-502
131. Singhrao SK, Neal JW, Morgan BP, Gasque P.. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol. 1999 ; 159 (2). 362-76
132. Siskova Z, Page A, O'Connor V, Perry VH. Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. Am J Pathol. 2009 ; 175 (4). 1610-21
133. Sogn CJ, Puchades M, Gundersen V.. Rare contacts between synapses and microglial processes containing high levels of Iba1 and actin - a postembedding immunogold study in the healthy rat brain. Eur J Neurosci. 2013 ; 38 (1). 2030-40
134. Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem. 2006 ; 96 (3). 706-18
135. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N. The classical complement cascade mediates CNS synapse elimination. Cell. 2007 ; 131 (6). 1164-78
136. Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Synuclein activates microglia in a model of Parkinson's disease. Neurobiol Aging. 2008 ; 29 (11). 1690-701
137. Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM. Neuroinflammatory phenotype in early Alzheimer's disease. Neurobiol Aging. 2013 ; 34 (4). 1051-9
138. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain. 2007 ; 130 (Pt 7). 1759-66
139. Tambuyzer BR, Ponsaerts P, Nouwen EJ. Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol. 2009 ; 85 (3). 352-70
140. Trager U, Andre R, Lahiri N, Magnusson-Lind A, Weiss A, Grueninger S. HTT-lowering reverses Huntington's disease immune dysfunction caused by NFkappaB pathway dysregulation. Brain. 2014 ; 137 (Pt 3). 819-33
141. Trager U, Tabrizi SJ. Peripheral inflammation in neurodegeneration. J Mol Med (Berl). 2013 ; 91 (6). 673-81
142. Tremblay ME, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010 ; 8 (11). e1000527
143. Tremblay ME, Zettel ML, Ison JR, Allen PD, Majewska AK. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia. 2012 ; 60 (4). 541-58
144. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J.. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009 ; 29 (13). 3974-80
145. Walsh S, Finn DP, Dowd E.. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat. Neuroscience. 2011 ; 175: 251-61
146. Wang CC, Wu CH, Shieh JY, Wen CY, Ling EA. Immunohistochemical study of amoeboid microglial cells in fetal rat brain. J Anat. 1996 ; 189 (Pt 3). 567-74
147. Wang G, Zhang Y, Chen B, Cheng J.. Preliminary studies on Alzheimer's disease using cDNA microarrays. Mech Ageing Dev. 2003 ; 124 (1). 115-24
148. Wei R, Jonakait GM. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J Neuroimmunol. 1999 ; 95 (1-2). 8-18
149. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci. 2002 ; 22 (5). 1763-71
150. Yamada J, Nakanishi H, Jinno S.. Differential involvement of perineuronal astrocytes and microglia in synaptic stripping after hypoglossal axotomy. Neuroscience. 2011 ; 182: 1-10
151. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci. 2014 ; 17 (3). 400-6
152. Zhang S, Wang XJ, Tian LP, Pan J, Lu GQ, Zhang YJ. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J Neuroinflammation. 2011 ; 8: 154